CERT

• The spoken and presentation materials incorrectly said the divested Regulatory and Medical Writing business generated approximately $17 million of 2025 adjusted EBITDA excluding unallocated overhead costs.
• The correct figure is approximately $17 million including unallocated overhead costs; excluding unallocated corporate expense that will remain with Certara, the figure is approximately $23 million.
• An updated version of the Q2 2026 earnings presentation has been posted on Certara's website at ir.certara.com under 'Financials & Filings—Quarterly Results'.
• The clarification has no impact on previously reported financial results, year-over-year comparisons, or the company's 2026 Financial Outlook.

7.01 Regulation FD Disclosure

• Leif E. Pedersen departed as President and Chief Commercial Officer of Certara, Inc., effective August 1, 2026.
• The company announced the departure on August 4, 2026.
• His employment will terminate without cause on December 31, 2026, and he will receive severance benefits per his existing employment agreement and the company's Executive Officer Severance Policy.
• The employment agreement with Certara USA, Inc. is dated July 30, 2020.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

• Software revenue grew 4% to $48.8 million; services revenue decreased 3% to $44.5 million.
• Net loss was $6.1 million, compared to net income of $1.5 million in Q2 2025.
• Adjusted EBITDA was $26.2 million, down 3% from $27.0 million in Q2 2025.
• Company reaffirmed 2026 revenue growth guidance of 0% to 4% for continuing operations.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Gallagher will continue as CFO through July 14, 2026, and will assist with the transition through the closing of the quarterly period ending June 30, 2026.
• Faiz Mohammed, age 53, was appointed Interim CFO, principal financial officer, and principal accounting officer, effective July 15, 2026.
• Mohammed has served as Senior Vice President, Finance and Treasurer since 2018 and has over 25 years of finance and accounting experience.
• Certara reaffirmed its 2026 financial guidance provided on May 11, 2026, in connection with the CFO transition announcement.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits

• Certara, Inc. held its 2026 annual meeting of stockholders on May 14, 2026.
• The ratification of RSM US LLP as independent auditor for fiscal 2026 passed with 141,730,429 votes for.
• The non-binding advisory vote on named executive officer compensation was approved with 120,333,107 votes for.
• The results were reported under Item 5.07 as required for matters submitted to a vote of security holders.

5.07 Submission of Matters to a Vote of Security Holders

• Software revenue grew 7% to $49.7 million; services revenue declined 4% to $57.2 million.
• Net loss was $8.8 million versus net income of $4.7 million in Q1 2025; adjusted EBITDA was $31.7 million, down 9%.
• On May 8, 2026, Certara completed the sale of its medical writing and related regulatory services business to Veristat for $85.0 million cash, with $15 million in escrow and up to $35 million earn-out.
• Full-year 2026 guidance: revenue $395-$405 million, adjusted EBITDA margin 30%-32%, adjusted diluted EPS $0.35-$0.41.

2.02 Results of Operations and Financial Condition · 8.01 Other Events · 9.01 Financial Statements and Exhibits

• Veristat will pay $100 million in cash at closing, subject to post-closing adjustments, plus up to $35 million in earn-out contingent consideration based on the Business's financial performance.
• Up to $15 million of the closing purchase price may be held in escrow if certain closing items are not satisfied.
• The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions including absence of legal restraints and completion of internal reorganization steps.
• The Business generated $50 million in revenue and $17 million in adjusted EBITDA in 2025, and includes approximately 220 employees.

1.01 Entry into a Material Definitive Agreement · 9.01 Financial Statements and Exhibits

• Cynthia Collins notified Certara of her resignation as a Class II director and Audit Committee member on March 27, 2026.
• Her resignation is effective May 14, 2026, the date of the 2026 annual meeting of stockholders.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements